Utility of Fecal Elastase-1 in Estimating Exocrine Pancreatic Function in Cystic Fibrosis: A Scoping Review. [PDF]
Sankararaman S +3 more
europepmc +1 more source
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Fecal Elastase-1 in Children With Cystic Fibrosis. [PDF]
Sankararaman S +5 more
europepmc +1 more source
Novel Predictive Strategy Using CA19-9 and Fecal Elastase Levels to Make Treatment Decisions for Resectable Pancreatic Cancer: A Retrospective Study. [PDF]
Kim HS +8 more
europepmc +1 more source
Elastase-1 (EL-1) fecal em pacientes pediátricos com fibrose cística
Viroj Wiwanitkit
doaj +1 more source
Pancreatic steatosis is associated with exocrine pancreatic dysfunction in children with MASLD: a prospective cross-sectional study. [PDF]
Daldaban Sarıca B +5 more
europepmc +1 more source
Protease-serpin-microbiome interactions in inflammatory bowel disease: toward integrated biomarkers of gut health. [PDF]
Almalki M +12 more
europepmc +1 more source
SCO‑792 alleviates HFD‑aggravated chronic pancreatitis by modulating the gut-pancreas axis via the AMPK/ACC and TLR4/NF‑κB signaling pathways. [PDF]
Kang Y +8 more
europepmc +1 more source
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Fat-Soluble Vitamin Status in 2 to 5 Year-Old Children Using a Cystic Fibrosis-Specific Multivitamin Formulation. [PDF]
Munck A +11 more
europepmc +1 more source
A microbiome meta-transcriptomics pipeline identifies a neutrophil elastase inhibitor that protects the colonic epithelial barrier. [PDF]
Stojkovic B +8 more
europepmc +1 more source

